Statin Citizen Petition: Coenzyme Effects Should Be Included In Label
This article was originally published in The Tan Sheet
Executive Summary
Statin labeling should be revised to carry a warning that drugs in the class deplete coenzyme Q10 levels and contribute to increased risk of myopathy, according to a citizen petition supplement filed with FDA